The Punch Lab · May 15, 2026 · Kifah Momin

Paraxanthine and Athletes — What the Early Research Shows

Athletes and active people want to know whether a product actually does something — not just whether it sounds good. Here's an honest breakdown of what the current research says about paraxanthine and physical and cognitive performance, with clear flags on what is human evidence, what is animal data, and what the limitations are.

The Honest Evidence Landscape

Paraxanthine as a standalone supplement ingredient is new. The research base is small. Most of the evidence relevant to athletes comes from two human trials and two animal studies — all funded by the same ingredient manufacturer. That context matters, and we will be clear about it throughout.

Human Evidence — Cognitive Performance After Exercise

The most directly relevant study for athletes is a 2024 double-blind, randomised crossover trial published in the Journal of the International Society of Sports Nutrition (Yoo et al., PMID: 38725238).

What they did

12 trained runners completed a 10km time trial under four conditions: 200mg paraxanthine, 200mg caffeine, 200mg paraxanthine + 200mg caffeine combined, and placebo. Cognitive function was measured before and after the run using standardised tests for executive function, reaction time, and sustained attention.

What they found

The paraxanthine group improved correct cognitive responses post-run by +6.8% (p=0.012)
The paraxanthine group showed significantly fewer perseverative errors than the caffeine group (−26.9%, p=0.026)
Paraxanthine produced faster post-exercise reaction times than placebo (−23.2%, p=0.029)
The caffeine group made more errors in cognitive testing by the end of the run
Paraxanthine was associated with fewer self-reported side effects (tachycardia, shortness of breath, nervousness) than caffeine
Adding caffeine to paraxanthine provided no additional cognitive benefit over paraxanthine alone

What it means

After a hard 10km run — when cognitive fatigue is at its highest — the paraxanthine group maintained and improved cognitive function, while the caffeine group showed more errors. For sport and training scenarios where decision-making, reaction time, and tactical awareness matter as much as physical output, this is a meaningful finding.

Caveats: n=12, industry-funded (Ingenious Ingredients LP), co-authors hold paraxanthine patents. Evidence is preliminary and requires independent replication.

Human Evidence — Cognitive Performance at Rest and During Recovery

The 2021 dose-response trial (Xing et al., Nutrients, PMID: 34960030) found that 100–200mg paraxanthine improved reaction time, working memory, executive function, and sustained attention compared with placebo in 12 healthy adults — both acutely and over 7 days. While not a sports-specific study, these cognitive measures are relevant for any activity requiring sharp decision-making.

Same caveats: n=12, industry-funded.

Animal Evidence — Physical Performance (Mice)

A 2022 study (Jäger et al., Nutrients, PMID: 35215543) tested paraxanthine in mice undergoing 4 weeks of treadmill training. Results showed:

Paraxanthine significantly increased forelimb grip strength (+17% vs control)
Treadmill exercise performance improved by +39% vs control
Muscle mass gains were observed in gastrocnemius and soleus muscles

Important flag: This is an animal study. Mouse physiology differs substantially from human physiology, and results from rodent performance studies do not reliably translate to human outcomes. These findings should not be cited as evidence of what paraxanthine will do to human athletic performance — only as a signal that warrants further investigation in human trials.

Animal Evidence — Memory and Neuroplasticity

A 2024 study (Jäger et al., Experimental Brain Research, PMID: 39617850) found that paraxanthine improved learning and memory in both young and aged rats compared with caffeine, with higher BDNF (brain-derived neurotrophic factor) levels in the paraxanthine groups.

Same flag: Rat study. Interesting mechanistic signal; not translatable as a direct claim about human memory or neuroplasticity.

What This Means for Athletes Using Pack a Punch

Based on the available human evidence, here is what can reasonably be said:

Paraxanthine at 200mg may support cognitive performance — reaction time, executive function, sustained attention — during and after demanding exercise
It may be associated with fewer jitter-like side effects than an equivalent caffeine dose in some people
It provides zero-caffeine stimulation, which is relevant for athletes who train at night, have caffeine sensitivity, or want to reduce caffeine dependence

What cannot reasonably be said from current evidence:

That paraxanthine improves physical performance metrics in humans (strength, endurance, power output) — no human data exists for this
That it is proven superior to caffeine for athletic performance overall — one small study under one condition is not definitive
That the animal muscle data translates to humans

Pack a Punch for Training

Pack a Punch is designed for people who train hard and need their mind to keep pace with their body — athletes, active professionals, and anyone whose training demands sharp focus alongside physical output. Mix one serve with 300ml of water 20–30 minutes before your session.

It is not a physical performance enhancer in the traditional pre-workout sense — no creatine, no beta-alanine, no citrulline. It is a cognitive-first energy concentrate that supports the mental side of performance. See how it compares to a pre-workout →

Shop Pack a Punch →

Sources

Yoo C, et al. Paraxanthine provides greater improvement in cognitive function than caffeine after performing a 10-km run. JISSN. 2024. PMID: 38725238
Xing D, et al. Dose-Response of Paraxanthine on Cognitive Function. Nutrients. 2021. PMID: 34960030
Jäger R, et al. Paraxanthine supplementation and muscle performance in mice. Nutrients. 2022. PMID: 35215543 [Animal study]
Jäger R, et al. Paraxanthine enhances memory and neuroplasticity more than caffeine in rats. Exp Brain Res. 2024. PMID: 39617850 [Animal study]